Close Menu

NEW YORK (GenomeWeb) – Phase Genomics said today that it has received a two-year, $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to develop an affordable, high-throughput Hi-C kit and computational analysis platform for microbiome research and discovery.

The firm said it had previously received a Phase I SBIR grant from the NIAID as well as an investment from WRF Capital and Congruent Ventures to develop the platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.